[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341763-105":59,"doc-detail-341763-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","plexinb1-inactivation-reprograms-immune-cells-in-the-tumor-microenvironment-inhibiting-breast-cancer-growth-and-metastatic-dissemination","PlexinB1 Inactivation Reprograms Immune Cells in the Tumor Microenvironment, Inhibiting Breast Cancer Growth and Metastatic Dissemination","","Semaphorin–plexin signaling shapes the tumor microenvironment (TME), and the high-affinity receptor Plexin-B1 (PLXNB1) is expressed in the TME. Targeting PLXNB1 in triplenegative murine breast carcinoma reduced primary tumor growth and metastatic dissemination, improving survival. PLXNB1 loss drove a pro-inflammatory M1 switch in tumor-associated macrophages, enhanced CD8+ T-cell infiltration, and shifted Th1/Th2 balance with antitumor gene signatures. PLXNB1 inactivation also increased responsiveness to anti-PD-1 blockade in vivo, and pharmacologic PLXNB1 inhibition enhanced anti-PD-1 antitumor activity in a preclinical model.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/plexinb1-inactivation-reprograms-immune-cells-in-the-tumor-microenvironment-inhibiting-breast-cancer-growth-and-metastatic-dissemination/341763/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/plexinb1-inactivation-reprograms-immune-cells-in-the-tumor-microenvironment-inhibiting-breast-cancer-growth-and-metastatic-dissemination/341763.png","ImageObject",300,407,{"name":92,"@type":93},"Levi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What question does the study address about PLXNB1 in breast cancer?","Question",{"text":112,"@type":113},"It examines whether Plexin-B1 (PLXNB1), expressed in the tumor microenvironment, has a functional role in cancer progression and metastatic dissemination.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does PLXNB1 inactivation affect the TME’s immune composition?",{"text":117,"@type":113},"PLXNB1 loss reprograms tumor-associated macrophages toward a pro-inflammatory M1 phenotype and increases CD8+ T-cell infiltration, along with a shift in the Th1/Th2 balance and an antitumor gene expression pattern.",{"name":119,"@type":110,"acceptedAnswer":120},"What is the relationship between PLXNB1 inactivation and anti-PD-1 immunotherapy?",{"text":121,"@type":113},"In the absence of PLXNB1, anti-PD-1 blockade efficacy is strongly enhanced, reducing tumor growth and distant metastasis; pharmacologic PLXNB1 inhibition similarly increases antitumor activity of anti-PD-1 in a preclinical model.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},341763,1790125844,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","PlexinB1 Inactivation Reprograms Immune Cells in the Tumor Microenvironment, Inhibiting Breast Cancer Growth and Metastatic Dissemination  \nGiulia Franzolin1,2, Serena Brundu1,2, Carina F. Cojocaru1,2, Aurora Curatolo1,2, Matteo Ponzo1, Roberta Mastrantonio3,4, Emiko Mihara5, Atsushi Kumanogoh6,7, Hiroaki Suga8, Junichi Takagi5, Luca Tamagnone3,4, and Enrico Giraudo1,2  \n|  |  | A |  | B | S |  | T | R |  | A |  | C | T |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n|  | Semaphorin–plexin signaling plays a major role in the tumor microenvironment (TME) . In particular, Semaphorin 4D (SEMA4D) has been shown to promote tumor growth and metastasis; however, the role of its high-affinity receptor Plexin-B1 (PLXNB1), which is expressed in the TME, is poorly understood. In this study, we directly targeted PLXNB1 in the TME of triplenegative murine breast carcinoma to elucidate its relevance in cancer progression. We found that primary tumor growth and metastatic dissemination were strongly reduced in PLXNB1-deficient mice, which showed longer survival. PLXNB1 loss in the TME induced a switch in the polarization of tumor-associated macrophages (TAM) toward a pro-inflammatory M1 phenotype and enhanced the infiltration of CD8+ T lymphocytes both in primary tumors and in distant metastases. Moreover, PLXNB1 deficiency promoted a shift in the Th1/Th2 balance of the T-cell\u003Cbr>􀀶 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | population and an antitumor gene signature, with the upregulation of Icos, Perforin-1, Stat3, and Ccl5 in tumor-infiltrating lymphocytes (TILs) . We thus tested the translational relevance of TME reprogramming driven by PLXNB1 inactivation for responsiveness to immunotherapy. Indeed, in the absence of PLXNB1, the efficacy of anti-PD-1 blockade was strongly enhanced, efficiently reducing tumor growth and distant metastasis. Consistent with this, pharmacological PLXNB1 blockade by systemic treatment with a specific inhibitor significantly hampered breast cancer growth and enhanced the antitumor activity of the anti-PD-1 treatment in a preclinical model. Altogether, these data indicate that PLXNB1 signaling controls the antitumor immune response in the TME and highlight this receptor as a promising immune therapeutic target for metastatic breast cancers. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |\n\nIntroduction  \nBreast cancer (BC) is one of the most frequent tumor types and the most common malignancy in women (1) . The tumor microenvironment (TME) is essential to dynamically regulate cancer progression, and due to its influence on the therapeutic outcome,  \n1Laboratory of Tumor Microenvironment, Candiolo Cancer Institute, FPOIRCCS, Candiolo, Italy. 2Department of Science and Drug Technology, University of Torino, Torino, Italy. 3Department Life Sciences and Public Health, Universit Cattolica del Sacro Cuore, Rome, Italy. 4Fondazione Policlinico Gemelli–IRCCS, Rome, Italy. 5Laboratory for Protein Synthesis and Expression, ","cbCainJjUxDnlQwI","https://ap.wps.com/l/cbCainJjUxDnlQwI","pdf",5668876,16,"English","# Introduction\n## Tumor microenvironment and immunotherapy context\n## Targeting immune cells and “cold-to-hot” tumor conversion","[{\"question\":\"What question does the study address about PLXNB1 in breast cancer?\",\"answer\":\"It examines whether Plexin-B1 (PLXNB1), expressed in the tumor microenvironment, has a functional role in cancer progression and metastatic dissemination.\"},{\"question\":\"How does PLXNB1 inactivation affect the TME’s immune composition?\",\"answer\":\"PLXNB1 loss reprograms tumor-associated macrophages toward a pro-inflammatory M1 phenotype and increases CD8+ T-cell infiltration, along with a shift in the Th1/Th2 balance and an antitumor gene expression pattern.\"},{\"question\":\"What is the relationship between PLXNB1 inactivation and anti-PD-1 immunotherapy?\",\"answer\":\"In the absence of PLXNB1, anti-PD-1 blockade efficacy is strongly enhanced, reducing tumor growth and distant metastasis; pharmacologic PLXNB1 inhibition similarly increases antitumor activity of anti-PD-1 in a preclinical model.\"}]","PlexinB1 Inactivation Reprograms Immune Cells in the Tumor Microenvironment, Inhibiting Breast Cancer Growth and Metastatic Dissemination | PDF",1790043650,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b4ac5771d4b376131dc8d516422f8e9f.webp",983,1315,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/000356ad91301c9ab37984c4ec818078.webp",982,1314,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b0b9237cf131c20de78067f7d4ce0053.webp",981,1312,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bff56a74b9d3db38f56d7fe0c7aa226b.webp",980,1311]